ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Tissue valves are preferable for patients with end-stage renal disease: an aggregate meta-analysis

Friday, August 5, 2016

Submitted by

CTSNet Staff

Source

Source Name: Journal of Cardiac Surgery

Source URL: http://onlinelibrary.wiley.com/doi/10.1111/jocs.12805/full

Author(s)

Salah E. Altarabsheh, Salil V. Deo, Shannon M. Dunlay, Yaqthan M. Obeidat, Patricia J. Erwin, Abeer Rababa'h, Nagaraju Sarabhu, Suparna Navale, Yang Hyun Cho, Harveen K. Lamba, Alan H. Markowitz and Soon J. Park

This was a meta-analysis of 15 retrospective studies involving 7123 valve prostheses performed in patients with end-stage renal disease (ESRD). The results showed that bleeding complications were significantly higher with mechanical valves and that structural degeneration of tissue valves during the follow-up period was low. The authors concluded that in patients with ESRD, tissue valves should be the prosthesis of choice.